• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Medical Imaging Markets, Volume V – Molecular Imaging

$2,995.00 – $5,990.00

Clear
SKU: KLI1350449 Categories: Diagnostics Market Research, Medical Imaging & In Vivo Testing Pages: 136
  • Description
  • Table of Contents
  • Latest reports

Description

Molecular imaging maps the locations of specific molecules and biomaterials within living tissue. As such, it has the potential to diagnose a disease, to monitor the course of that disease, and possibly facilitate treatment. Molecular imaging has developed into a promising new strategy for the diagnosis, evaluation and treatment of disease.

The final volume in Kalorama’s Medical Imaging Markets series: Medical Imaging Markets, Volume V, Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:

  • PET
  • SPECT-Gamma Camera Systems
  • MRI
  • CT
  • Ultrasound
  • Fusion Imaging
  • Optical Imaging

Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets, Volume V, Molecular Imaging includes:

  • Complete Overview and Explanation of modalities and key applications
  • Over 35 Figures and Tables to make market data accessible to users.
  • Review of Imaging Agents in Clinical Trials, or that are recently introduced.
  • Market Size and Forecasts are developed through 2011.
  • Profiles of Top Competitors in the industry including: including Gamma Medica, GE Healthcare, Hiatchi, OptoSonics, Philips, Siemens and Toshiba, among others.

Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:

  • PET Targets Alzheimer’s Disease
  • Rubidium-based PET
  • PET Diagnoses Pancreas Defects
  • Hyper-Cest MRI
  • Molecular Breast Imaging
  • Drug Abuse
  • Radiotracers and Drug Addiction
  • Whole-Body PET
  • PET/CT for Ovarian Cancer
  • SPECT for Lower Back Pain
  • Contrast-Enhanced Ultrasound

As part of Kalorama’s trusted information-gathering process, the information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence with medical imaging company executives were the primary method of gathering information and developing forecasts.

Table of Contents

Chapter One: Executive Summary

  • 1.1 Molecular Basis of Cell Function
  • 1.2 Driving Healthcare
  • 1.3 Two Components
  • 1.4 Key Modalities
  • 1.5 World Market Summary
  • 1.5.1 Market Drivers and Challenges
  • 1.5.2 Growth Analysis
  • 1.6 Methodology

Chapter Two: Introduction

  • 2.1 Background and Definitions
    • 2.1.1 Nuclear Medicine
    • 2.1.2 Imaging Agents and Traditional Anatomic Modalities
  • 2.2 New Direction for Medicine
  • 2.3 Modalities and Applications
    • 2.3.1 Nuclear Medicine
    • 2.3.1.1 Positron Emission Tomography (PET)
    • 2.3.1.2 Single Photon Emission Computed Tomography (SPECT) and Gamma Cameras
    • 2.3.2 Computed Tomography (CT)
    • 2.3.3 Magnetic Resonance Imaging (MRI)
    • 2.3.4 Ultrasound
    • 2.3.5 Fusion Imaging
    • 2.3.5.1 PET/CT
    • 2.3.5.2 SPECT/CT
    • 2.3.6 Optical Imaging, Near Infrared (NIR)
  • 2.4 Drivers
  • 2.5 Issues and Challenges
    • 2.5.1 Imaging Agent Delivery and Observation
    • 2.5.2 SPECT/CT and Targeted Imaging
    • 2.5.3 Optical Technology
    • 2.5.4 Application-Specific Controversies

Chapter Three: Promising Research

  • 3.1 PET Targets Alzheimer’s Disease
  • 3.2 Rubidium-Based PET
  • 3.3 PET Diagnoses Pancreas Defects
  • 3.4 Hyper-Cest MRI
  • 3.5 Molecular Breast Imaging
  • 3.6 Drug Abuse
  • 3.7 Radiotracers and Drug Addiction
  • 3.8 Whole-Body PET
  • 3.9 PET/CT for Ovarian Cancer
  • 3.10 SPECT for Lower Back Pain
  • 3.11 Contrast-Enhanced Ultrasound
  • 3.12 Preclinical Drug Research

Chapter Four: Markets

  • 4.1 Overview
  • 4.2 Procedures
  • 4.3 Market Forecasts
    • 4.3.1 PET
    • 4.3.2 SPECT-Gamma Camera Systems
    • 4.3.3 Molecular Magnetic Resonance Imaging (MRI)
    • 4.3.4 Molecular Computed Tomography (CT)
    • 4.3.5 Ultrasound
    • 4.3.6 Fusion Imaging
    • 4.3.7 Optical Imaging
  • Chapter Five: Corporate Profiles
    • 5.1 Agilent Technologies
    • 5.2 Bioscan
    • 5.3 Capintec Inc.
    • 5.4 Digirad Corp
    • 5.5 Gamma Medica Inc
    • 5.6 GE Healthcare
    • 5.7 Hitachi Medical Systems America Inc.
    • 5.8 IS2 Medical Systems
    • 5.9 MIR Preclinical Services
    • 5.10 OptoSonics Inc.
    • 5.11 Philips Medical Systems
    • 5.12 Positron Corp.
    • 5.12 Positron Corp.
    • 5.13 Siemens Medical Solutions
    • 5.14 Spectrum Dynamics Ltd.
    • 5.15 Toshiba America Medical Systems
    • 5.16 UltraSPECT Ltd.
    • 5.17 VisEn Medical Inc.
    • 5.18 Zecotek Medical Systems
  • list of exhibits
  • Chapter One: Executive Summary
    • Exhibit 1 Market Summary: World Market for Molecular Imaging 2007-2011
  • Chapter Two: Introduction
    • Exhibit 2: Key Liquid Radionuclides
  • Chapter Four: Markets
    • Exhibit 3: Worldwide Distribution of SPECT Procedures by Specialty 2006
    • Exhibit 4: U.S. Distribution of SPECT Procedures by Specialty 2006
    • Exhibit 5: Worldwide Distribution of PET Procedures by Specialty 2006
    • Exhibit 6: U.S. Distribution of PET Procedures by Specialty 2006
    • Exhibit 7: Worldwide Geographic Distribution of Molecular CT Procedures by Region (U.S., Europe, ROW) 2006
    • Exhibit 8: Worldwide Geographic Distribution of Molecular MRI Procedures by Region (U.S., Europe, ROW) 2006
    • Exhibit 9: World Medical Market for PET Systems Dollar Volume 2007-2011
    • Exhibit 10: U.S. Medical Market for PET Systems Dollar Volume 2007-2011
    • Exhibit 11: World Medical Market for PET Systems Unit Sales 2007-2011
    • Exhibit 12: U.S. Medical Market for PET Systems Unit Sales 2007-2011
    • Exhibit 13: World Medical PET Systems Estimated Installed Base by Region (U.S. vs Non-U.S.) 2006
    • Exhibit 14: World Medical Market for SPECT Systems Dollar Volume 2007-2011
    • Exhibit 15: U.S. Medical Market for SPECT Systems Dollar Volume 2007-2011
    • Exhibit 16: World Medical Market for SPECT Systems Unit Sales 2007-2011
    • Exhibit 17: U.S. Medical Market for SPECT Systems Unit Sales 2007-2011
    • Exhibit 18: World Medical SPECT Systems Estimated Installed Base by Region (U.S. vs Non-U.S.) 2006
    • Exhibit 19: World Medical Market for Molecular MRI Systems Dollar Volume 2007-2011
    • Exhibit 20: U.S. Medical Market for Molecular MRI Systems Dollar Volume 2007-2011
    • Exhibit 21: World Medical Market for Molecular CT Systems Dollar Volume 2007-2011
    • Exhibit 22: U.S. Medical Market for Molecular CT Systems Dollar Volume 2007-2011
    • Exhibit 23: World Medical Market for Molecular Ultrasound Systems Dollar Volume 2007-2011
    • Exhibit 24: U.S. Medical Market for Molecular Ultrasound Systems Dollar Volume 2007-2011
    • Exhibit 25: World Medical Market for Molecular PET/CT 2007-2011
    • Exhibit 26: U.S. Medical Market for Molecular PET/CT 2007-2011
    • Exhibit 27: World Medical Market for Molecular SPECT/CT 2007-2011
    • Exhibit 28: U.S. Medical Market for Molecular SPECT/CT 2007-2011
    • Exhibit 29: World Market for Molecular Imaging by Modality (PET, SPECT, CT, MRI, Ultrasound, PET/CT) 2007, 2009, 2011

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00
  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal...U.S. Market for Home Care Products, 5th Edition
Scroll to top